Earnest Partners LLC Reduces Holdings in Cabot Corporation $CBT

Earnest Partners LLC reduced its stake in shares of Cabot Corporation (NYSE:CBT) by 1.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,189,738 shares of the specialty chemicals company’s stock after selling 39,783 shares during the quarter. Cabot comprises approximately 1.1% of Earnest Partners LLC’s portfolio, making the stock its 21st largest holding. Earnest Partners LLC owned about 0.06% of Cabot worth $242,580,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. NewEdge Advisors LLC grew its holdings in shares of Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Cabot by 32.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after purchasing an additional 108,645 shares during the last quarter. Empowered Funds LLC lifted its holdings in shares of Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after purchasing an additional 14,260 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Cabot by 3.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after purchasing an additional 4,048 shares during the period. Finally, Geneos Wealth Management Inc. grew its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares during the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Jefferies Financial Group reiterated a “buy” rating and issued a $85.00 price objective on shares of Cabot in a research note on Wednesday, February 4th. UBS Group lifted their target price on shares of Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Mizuho set a $75.00 price target on shares of Cabot and gave the company a “neutral” rating in a research report on Wednesday, February 4th. JPMorgan Chase & Co. decreased their price target on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research note on Friday, November 28th. Finally, Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Cabot currently has an average rating of “Hold” and an average target price of $73.75.

Cabot Stock Up 0.9%

Cabot stock opened at $69.49 on Friday. The stock has a 50 day moving average of $73.13 and a two-hundred day moving average of $71.01. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $84.89. The stock has a market capitalization of $3.63 billion, a price-to-earnings ratio of 12.17, a PEG ratio of 9.16 and a beta of 0.86. The company has a current ratio of 1.67, a quick ratio of 1.09 and a debt-to-equity ratio of 0.49.

Cabot (NYSE:CBT) last released its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.13. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The business had revenue of $849.00 million for the quarter, compared to analyst estimates of $889.11 million. During the same quarter in the previous year, the company posted $1.76 earnings per share. The company’s revenue for the quarter was down 11.1% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, research analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Friday, February 27th were paid a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend was Friday, February 27th. Cabot’s payout ratio is currently 31.52%.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.